Perspectives on systematic capacity building in pharmaceutical regulation for regulators of medical products
Having a robust, integrated regulatory system is important for ensuring the availability of safe and efficacious medical products of good quality and for protecting public health. However, less than 30% of countries globally have reached the required regulatory maturity level three, with low- and mi...
Main Authors: | Luther Gwaza, Andrew Chemwolo, Mario Musonda, Rutendo Kuwana, Admire Dube |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2024-04-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2024.1394562/full |
Similar Items
-
Collaborative reliance in medicine safety and quality regulation: Investigation of experiences in handling N-nitrosamine impurities among ZaZiBoNa participating countries
by: Patience P. Shabangu, et al.
Published: (2022-09-01) -
Position paper to facilitate patient access to radiopharmaceuticals: considerations for a suitable pharmaceutical regulatory framework
by: Aruna Korde, et al.
Published: (2024-01-01) -
Situation analysis on the regulation of nanomedicines in Southern Africa
by: Linda G. Mudyiwenyama, et al.
Published: (2023-04-01) -
The domestication of the African Union model law on medical products regulation: Perceived benefits, enabling factors, and challenges
by: Bakani Mark Ncube, et al.
Published: (2023-01-01) -
Evaluation of the Legal Framework for Building Fire Safety Regulations in Spain
by: Amaya Osácar, et al.
Published: (2021-02-01)